PROFUSA, INC. Operating Cash Flow
PROFUSA, INC. (PFSA) reported Operating Cash Flow of -$5.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-19
- PROFUSA, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.63M.
- PROFUSA, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.58M.
- PROFUSA, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$5.13M.
- PROFUSA, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$9.99M.
- PROFUSA, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$2.06M.
- PROFUSA, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$581.19K.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 8 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | -$5.21M 10-Q · filed 2026-08-19 | -$10.34M derived: sum of 3 quarters · filed 2026-08-19 | -$20.33M derived: sum of 4 quarters · filed 2026-08-19 | |||||
| 2026-03-31 | -$2.58M 10-Q · filed 2026-05-15 | -$7.71M derived: sum of 2 quarters · filed 2026-05-15 | -$17.70M derived: sum of 3 quarters · filed 2026-05-15 | -$18.29M derived: sum of 4 quarters · filed 2026-08-19 | |||||
| 2025-12-31 | -$5.13M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | -$15.12M derived: sum of 2 quarters · filed 2026-05-01 | -$15.71M derived: sum of 3 quarters · filed 2026-08-19 | -$16.25M S-1/A · filed 2026-05-01 | |||||
| 2025-09-30 | -$9.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$10.58M derived: sum of 2 quarters · filed 2026-08-19 | -$11.12M 10-Q · filed 2025-11-19 | -$11.36M derived: sum of 4 quarters · filed 2026-08-19 | |||||
| 2025-06-30 | -$589.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | -$1.13M 10-Q · filed 2026-08-19 | -$501.61K 10-Q · filed 2025-08-14 | -$1.36M derived: sum of 3 quarters · filed 2026-08-19 | -$2.52M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-03-31 | -$537.00K 10-Q · filed 2026-05-15 | -$362.44K 10-Q · filed 2025-06-13 | -$775.00K derived: sum of 2 quarters · filed 2026-05-15 | -$1.93M derived: sum of 3 quarters · filed 2026-05-15 | -$2.32M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | -$238.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | -$1.39M derived: sum of 2 quarters · filed 2026-05-01 | -$1.79M derived: sum of 3 quarters · filed 2026-05-01 | -$2.07M S-1/A · filed 2026-05-01 | -$1.30M 10-K · filed 2025-03-31 | ||||
| 2024-09-30 | -$1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$1.55M derived: sum of 2 quarters · filed 2025-11-19 | -$1.83M 10-Q · filed 2025-11-19 | -$969.30K 10-Q · filed 2024-12-17 | -$2.17M derived: sum of 4 quarters · filed 2025-11-19 | ||||
| 2024-06-30 | -$394.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$675.73K 10-Q · filed 2025-08-14 | -$1.02M derived: sum of 3 quarters · filed 2025-08-14 | -$1.50M derived: sum of 4 quarters · filed 2025-08-14 | |||||
| 2024-03-31 | -$280.85K 10-Q · filed 2025-06-13 | -$626.06K derived: sum of 2 quarters · filed 2025-06-13 | -$1.11M derived: sum of 3 quarters · filed 2025-06-13 | -$1.38M derived: sum of 4 quarters · filed 2025-06-13 | |||||
| 2023-12-31 | -$345.21K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$824.99K derived: sum of 2 quarters · filed 2025-03-31 | -$1.10M derived: sum of 3 quarters · filed 2025-03-31 | -$2.06M 10-K · filed 2025-03-31 | |||||
| 2023-09-30 | -$479.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-17 | -$753.04K derived: sum of 2 quarters · filed 2024-12-17 | -$1.72M 10-Q · filed 2024-12-17 | -$1.90M derived: sum of 4 quarters · filed 2024-12-17 | |||||
| 2023-06-30 | -$273.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-15 | -$1.24M 10-Q · filed 2024-11-15 | -$1.42M derived: sum of 3 quarters · filed 2024-11-15 | -$1.53M derived: sum of 4 quarters · filed 2024-11-15 | |||||
| 2023-03-31 | -$966.61K 10-Q · filed 2024-10-09 | -$1.15M derived: sum of 2 quarters · filed 2024-10-09 | -$1.25M derived: sum of 3 quarters · filed 2024-10-09 | -$1.32M derived: sum of 4 quarters · filed 2024-10-09 | |||||
| 2022-12-31 | -$179.35K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$287.20K derived: sum of 2 quarters · filed 2024-02-26 | -$350.84K derived: sum of 3 quarters · filed 2024-02-26 | -$581.19K 10-K · filed 2024-02-26 | |||||
| 2022-09-30 | -$107.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | -$171.49K derived: sum of 2 quarters · filed 2023-11-20 | -$401.84K 10-Q · filed 2023-11-20 | ||||||
| 2022-06-30 | -$63.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$293.99K 10-Q · filed 2023-08-14 | |||||||
| 2022-03-31 | -$230.35K 10-Q · filed 2023-05-17 | ||||||||
| 2021-12-31 | -$662.39K 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |